AbbVie Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
285 result(s) found, displaying 11 to 20
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EPKINLY epcoritamab 48mg/0.8mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EPKINLY epcoritamab 4mg/0.8mL concentrate solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SKYRIZI risankizumab 180 mg/1.2 mL solution for injection pre-filled cartridge with on-body delivery system.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ALPHAGAN P 1.0 brimonidine tartrate 1 mg/mL eye drop bottle.
-
Jan-2025Prescription medicine evaluationActive ingredient: mirvetuximab soravtansine.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - Bag, medical device, reusable.
-
-
Australian Public Assessment Report (AusPAR)Vyalev (foslevodopa and foscarbidopa) was approved to treat idiopathic Parkinson’s disease with severe motor fluctuations despite optimised alternative pharmacological treatment.
-
-
Cancellation by sponsorRequested by Abbvie Pty Ltd